The potential for an enhanced role for MRI in radiation-therapy treatment planning

Technology in Cancer Research and Treatment

Volumn 12, Issue 5, 2013, Pages 429-446

  Metcalfe, P ^a   Liney, G P ^b,c   Holloway, L ^a,c,d,e   Walker, A ^a   Barton, M ^c,d   Delaney, G P ^c,d   Vinod, S ^c,d   Tome W ^f,g  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^c LIVERPOOL HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Mri; Radiation; Radiation therapy; Therapy treatment planning

Indexed keywords

LACTIC ACID; CONTRAST MEDIUM;

ARTERIOVENOUS MALFORMATION; BRAIN; BREAST CANCER; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCED MRI; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPERPOLARIZATION; HYPOXIA; LUNG CANCER; MAGNETIC RESONANCE ANGIOGRAPHY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; STEREOTACTIC RADIOSURGERY; TREATMENT PLANNING; TRIGEMINAL NERVE; TUMOR VOLUME; UTERINE CERVIX CANCER; BRAIN NEOPLASMS; BREAST NEOPLASMS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEAD AND NECK NEOPLASMS; IMAGE PROCESSING; LUNG NEOPLASMS; MALE; NEOPLASMS; ORGANS AT RISK; PROSTATIC NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS; ORGANS AT RISK; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 84884158908     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500342     Document Type: Review

References (100)

1. Tubiana, M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91, 4-15 (2009). DOI: 10.1016/j.radonc.2008.12.016
2. Desar, I., Van Herpen, C., Van Laarhoven, H., Barentsz, J., Oyen, W., Van Der Graaf, W. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. Cancer treatment reviews 35, 309-321 (2009). DOI: 10.1016/j. ctrv.2008.12.001
3. Fallone, B., Carlone, M., Murray, B., Rathee, S., Stanescu, T., Steciw, S., Wachowicz, K., Kirkby, C. TU-C-M100F-01: Development of a linac-MRI system for real-time ART. Medical Physics 34, 2547 (2007). DOI: 10.1118/1.2761342
4. Raaymakers, B., Lagendijk, J., Overweg, J., Kok, J., Raaijmakers, A., Kerkhof, E., van der Put, R., Meijsing, I., Crijns, S., Benedosso, F. Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept. Physics in Medicine and Biology 54, N229 (2009). DOI: 10.1088/0031-9155/54/12/N01
5. Oborn, B., Metcalfe, P., Butson, M., Rosenfeld, A., Keall, P. Electron contamination modeling and skin dose in 6 MV longitudinal field MRIgRT: Impact of the MRI and MRI fringe field. Medical Physics 39, 874 (2012). DOI: 10.1118/1.3676181
6. Raaymakers, B., Raaijmakers, A., Lagendijk, J. Feasibility of MRI guided proton therapy: magnetic field dose effects. Physics in Medicine and Biology 53, 5615 (2008). DOI: 10.1088/0031-9155/53/20/003
7. Mazaheri, Y., Shukla-Dave, A., Muellner, A., Hricak, H. MRI of the prostate: Clinical relevance and emerging applications. Journal of Magnetic Resonance Imaging 33, 258-274 (2011). DOI: 10.1002/ jmri.22420
8. Philpotts, L. E. Comprehensive breast imaging 2010. Seminars in Roentgenology 46, 7-17 (2011). DOI: 10.1053/j.ro.2010.06.005
9. Hounsfield, G. N. Computerized transverse axial scanning (tomography): Part 1. Description of system. British Journal of Radiology 46, 1016-1022 (1973). DOI: 10.1259/0007-1285-46-552-1016
10. Metcalfe, P. E., Kron, T., Hoban, P. The physics of radiotherapy X-rays and electrons. (2007).
11. Garcia-Alvarez, R., Liney, G. P., Beavis, A. W. Repeatability of functional MRI for conformal avoidance radiotherapy planning. Journal of Magnetic Resonance Imaging 23, 108-114 (2006). DOI: 10.1002/ jmri.20493
12. Kovacs, A., Hadjiev, J., Lakosi, F., Antal, G., Vandulek, C., Somogyine Ezer E., Bogner, P., Horvath, A., Repa, I. Dynamic MR based analysis of tumor movement in upper and mid lobe localized lung cancer. Pathology & Oncology Research 15, 269-277 (2009). DOI: 10.1007/s12253-008-9101-5
13. Ogawa, S., Lee, T. M., Nayak, A. S., Glynn, P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magnetic Resonance in Medicine 14, 68-78 (1990). DOI: 10.1002/mrm.1910140108
14. Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B. W., Lee, T. Y., Mayr, N. A., Parker, G. J. M. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. Journal of Magnetic Resonance Imaging 10, 223-232 (1999). DOI: 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S
15. Vandecaveye, V., De Keyzer, F., Nuyts, S., Deraedt, K., Dirix, P., Hamaekers, P., Vander Poorten, V., Delaere, P., Hermans, R. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo) radiotherapy: correlation between radiologic and histopathologic findings. International Journal of Radiation Oncology* Biology* Physics 67, 960-971 (2007). DOI: 10.1016/j. ijrobp.2006.09.020
16. Srinivasan, A., Dvorak, R., Perni, K., Rohrer, S., Mukherji, S. Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience. American Journal of Neuroradiology 29, 40-44 (2008). DOI: 10.3174/ajnr.A0743
17. Bourne, R., Kurniawan, N., Cowin, G., Sved, P., Watson, G. 16 T Diffusion microimaging of fixed prostate tissue: preliminary findings. Magnetic Resonance in Medicine 66, 244-247 (2011). DOI: 10.1002/ mrm.22778
18. Ling, C. C., Humm, J., Larson, S., Amols, H., Fuks, Z., Leibel, S., Koutcher, J. A. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. International Journal of Radiation Oncology* Biology* Physics 47, 551-560 (2000). DOI: 10.1016/S0360-3016(00)00467-3
19. Kim, Y., Tomé, W. A. Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes. International Journal of Radiation Oncology* Biology* Physics 66, 1528-1542 (2006). DOI: 10.1016/j. ijrobp.2006.08.032
20. Star-Lack, J., Spielman, D., Adalsteinsson, E., Kurhanewicz, J., Terris, D. J., Vigneron, D. B. In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. Journal of Magnetic Resonance 133, 243-254 (1998). DOI: 10.1006/jmre.1998.1458
21. Kwock, L., Smith, J. K., Castillo, M., Ewend, M. G., Collichio, F., Morris, D. E., Bouldin, T. W., Cush, S. Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer. The Lancet Oncology 7, 859-868 (2006). DOI: 10.1016/ S1470-2045(06)70905-6
22. Frahm, J., Haase, A., Matthaei, D. Rapid NMR imaging of dynamic processes using the FLASII technique. Magnetic Resonance in Medicine 3, 321-327 (1986). DOI: 10.1002/mrm.1910030217
23. Fain, S., Schiebler, M. L., McCormack, D. G., Parraga, G. Imaging of lung function using hyperpolarized helium-3 magnetic resonance imaging: review of current and emerging translational methods and applications. Journal of Magnetic Resonance Imaging 32, 1398-1408 (2010). DOI: 10.1002/jmri.22375
24. Hodge, C., Tomé, W. A., Fain, S., Bentzen, S., Mehta, M. On the use of hyperpolarized helium MRI for conformal avoidance lung radiotherapy. Medical Dosimetry 35, 297-303 (2011). DOI: 10.1016/j. meddos.2009.09.004
25. Adams, R. W., Aguilar, J. A., Atkinson, K. D., Cowley, M. J., Elliott, P. I. P., Duckett, S. B., Green, G. G. R., Khazal, I. G., López-Serrano, J., Williamson, D. C. Reversible interactions with para-hydrogen enhance NMR sensitivity by polarization transfer. Science 323, 1708-1711 (2009). DOI: 10.1126/science.1168877
26. Nelson, S., Vigneron, D., Kurhanewicz, J., Chen, A., Bok, R., Hurd, R. DNP-hyperpolarized 13 C magnetic resonance metabolic imaging for cancer applications. Applied Magnetic Resonance 34, 533-544 (2008). DOI: 10.1007/s00723-008-0136-2
27. Nelson, S. J., Cha, S. Imaging glioblastoma multiforme. The Cancer Journal 9, 134 (2003). DOI: 10.1097/00130404-200303000-00009
28. Essig, M., Schlemmer, H. P., Tronnier, V., Hawighorst, H., Wirtz, R., Van Kaick, G. Fluid-attenuated inversion-recovery MR imaging of gliomatosis cerebri. European Radiology 11, 303-308 (2001). DOI: 10.1007/s003300000587
29. Tomé, W. A., Mehta, M. P., Meeks, S. L., Buatti, J. M. Fractionated stereotactic radiotherapy: present and future. Technol. in Cancer Res and Treat 1, 153-172 (2002).
30. Petereit, D., Mehta, M., Turski, P., Levin, A., Strother, C., Mistretta, C., Mackie, R., Gehring, M., Kubsad, S., Kinsella, T. Treatment of arteriovenous malformations with stereotactic radiosurgery employing both magnetic resonance angiography and standard angiography as a database. International Journal of Radiation Oncology*, Biology*, Physics 25, 309-313 (1993). DOI: 10.1016/0360-3016(93)90353-W
31. Richards, G. M., Bradley, K. A., Tomé, W. A., Bentzen, S. M., Resnick, D. K., Mehta, M. P. Linear accelerator radiosurgery for trigeminal neuralgia. Neurosurgery 57, 1193 (2005). DOI: 10.1227/01. NEU.0000186015.01179.70
32. Hamstra, D. A., Galbán, C. J., Meyer, C. R., Johnson, T. D., Sundgren, P. C., Tsien, C., Lawrence, T. S., Junck, L., Ross, D. J., Rehemtulla, A. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. Journal of Clinical Oncology 26, 3387-3394 (2008). DOI: 10.1200/JCO.2007.15.2363
33. Mardor, Y., Pfeffer, R., Spiegelmann, R., Roth, Y., Maier, S. E., Nissim, O., Berger, R., Glicksman, A., Baram, J., Orenstein, A. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. Journal of Clinical Oncology 21, 1094-1100 (2003). DOI: 10.1200/JCO.2003.05.069
34. Kovács, Á., Tóth, L., Glavák, C., Liposits, G., Hadjiev, J., Antal, G., Emri, M., Vandulek, C., Repa, I. Integrating functional MRI information into conventional 3D radiotherapy planning of CNS tumors. Is it worth it? Journal of Neurooncology 105, 629-637 (2011). DOI: 10.1007/s11060-011-0633-2
35. Goldman, M., Boxerman, J. L., Rogg, J. M., Norén, G. Utility of apparent diffusion coefficient in predicting the outcome of gamma knife-treated brain metastases prior to changes in tumor volume: a preliminary study. Special Supplements 105, 175-182 (2006).
36. Chang, J., Thakur, S., Perera, G., Kowalski, A., Huang, W., Karimi, S., Hunt, M., Koutcher, J., Fuks, Z., Amols, H. Image-fusion of MR spectroscopic images for treatment planning of gliomas. Medical Physics 33, 32 (2006). DOI: 10.1118/1.2128497
37. Payne, G., Leach, M. Applications of magnetic resonance spectroscopy in radiotherapy treatment planning. British Journal of Radiology 79, S16-S26 (2006). DOI: 10.1259/bjr/84072695
38. Braams, J. W., Pruim, J., Freling, N., Nikkels, P., Roodenburg, J., Boering, G., Vaalburg, W., Vermey, A. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 36, 211 (1995).
39. Nishioka, T., Shiga, T., Shirato, H., Tsukamoto, E., Tsuchiya, K., Kato, T., Ohmori, K., Yamazaki, A., Aoyama, H., Hashimoto, S. Image fusion between 18 FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. International Journal of Radiation Oncology* Biology* Physics 53, 1051-1057 (2002). DOI: 10.1016/S0360-3016(02)02854-7
40. Al-Hallaq, H. A., Mell, L. K., Bradley, J. A., Chen, L. F., Ali, A. N., Weichselbaum, R. R., Newstead, G. M., Chmura, S. J. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer 113, 2408-2414 (2008). DOI: 10.1002/cncr.23872
41. Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., Ioffe, O. B. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233, 830-849 (2004). DOI: 10.1148/ radiol.2333031484
42. Bluemke, D. A., Gatsonis, C. A., Chen, M. H., DeAngelis, G. A., DeBruhl, N., Harms, S., Heywang-Köbrunner, S. H., Hylton, N., Kuhl, C. K., Lehman, C. Magnetic resonance imaging of the breast prior to biopsy. JAMA: The Journal of the American Medical Association 292, 2735-2742 (2004). DOI: 10.1001/jama.292.22.2735
43. Fischer, U., Kopka, L., Grabbe, E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach1. Radiology 213, 881-888 (1999).
44. Hata, T., Takahashi, H., Watanabe, K., Takahashi, M., Taguchi, K., Itoh, T., Todo, S. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. Journal of the American College of Surgeons 198, 190-197 (2004). DOI: 10.1016/j.jamcollsurg.2003.10.008
45. Pengel, K., Loo, C., Teertstra, H., Muller, S., Wesseling, J., Peterse, J., Bartelink, H., Rutgers, E., Gilhuijs, K. G. A. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Research and Treatment 116, 161-169 (2009). DOI: 10.1007/s10549-008-0182-3
46. Tendulkar, R. D., Chellman-Jeffers, M., Rybicki, L. A., Rim, A., Kotwal, A., Macklis, R., Obi, B. B. Preoperative breast magnetic resonance imaging in early breast cancer. Cancer 115, 1621-1630 (2009). DOI: 10.1002/cncr.24172
47. Uematsu, T., Yuen, S., Kasami, M., Uchida, Y. Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer. Breast Cancer Research and Treatment 112, 461-474 (2008). DOI: 10.1007/s10549-008-9890-y
48. Van Goethem, M., Schelfout, K., Dijckmans, L., Van Der Auwera, J. C., Weyler, J., Verslegers, I., Biltjes, I., De Schepper, A. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. European Radiology 14, 809-816 (2004). DOI: 10.1007/ s00330-003-2146-7
49. Hurkmans, C. W., Borger, J. H., Pieters, B. R., Russell, N. S., Jansen, E. P. M., Mijnheer, B. J. Variability in target volume delineation on CT scans of the breast. International Journal of Radiation Oncology* Biology* Physics 50, 1366-1372 (2001). DOI: 10.1016/ S0360-3016(01)01635-2
50. Giezen, M., Kouwenhoven, E., Scholten, A. N., Coerkamp, E. G., Heijenbrok, M., Jansen, W. P. A., Mast, M. E., Petoukhova, A. L., Struikmans, H. Magnetic resonance imaging-versus computed tomography-based target volume delineation of the glandular breast tissue (clinical target volume breast) in breast-conserving therapy: an exploratory study. International Journal of Radiation Oncology*, Biology*, Physics 81, 804-811 (2011). DOI: 10.1016/j. ijrobp.2010.07.004
51. Jones, H. A., Antonini, N., Hart, A. A. M., Peterse, J. L., Horiot, J. C., Collin, F., Poortmans, P. M., Oei, S. B., Collette, L., Struikmans, H. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. Journal of Clinical Oncology 27, 4939-4947 (2009). DOI: 10.1200/JCO.2008.21.5764
52. Ahn, K. H., Hargreaves, B. A., Alley, M. T., Horst, K. C., Luxton, G., Daniel, B. L., Hristov, D. MRI guidance for accelerated partial breast irradiation in prone position: imaging protocol design and evaluation. International Journal of Radiation Oncology* Biology* Physics 75, 285-293 (2009). DOI: 10.1016/j.ijrobp.2009.03.063
53. Kirby, A. M., Yarnold, J. R., Evans, P. M., Morgan, V. A., Schmidt, M. A., Scurr, E. D., deSouza, N. M. Tumor bed delineation for partial breast and breast boost radiotherapy planned in the prone position: what does MRI add to X-ray CT localization of titanium clips placed in the excision cavity wall? International Journal of Radiation Oncology* Biology* Physics 74, 1276-1282 (2009). DOI: 10.1016/j. ijrobp.2009.02.028
54. Schmitz, A. C., van den Bosch, M. A. A. J., Loo, C. E., Mali, W. P. T. M., Bartelink, H., Gertenbach, M., Holland, R., Peterse, J. L., Rutgers, E. J. T., Gilhuijs, K. G. Precise correlation between MRI and histopathology-exploring treatment margins for MRI-guided localized breast cancer therapy. Radiotherapy and Oncology 97, 225-232 (2010). DOI: 10.1016/j.radonc.2010.07.025
55. Mack, M. G., Balzer, J. O., Straub, R., Eichler, K., Vogl, T. J. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes1. Radiology 222, 239-244 (2002). DOI: 10.1148/ radiol.2221010225
56. Plathow, C., Klopp, M., Fink, C., Sandner, A., Hof, H., Puderbach, M., Herth, F., Schmähl, A., Kauczor, H. Quantitative analysis of lung and tumour mobility: comparison of two time-resolved MRI sequences. British Journal of Radiology 78, 836-840 (2005). DOI: 10.1259/bjr/29483804
57. Blackall, J., Ahmad, S., Miquel, M., McClelland, J., Landau, D., Hawkes, D. MRI-based measurements of respiratory motion variability and assessment of imaging strategies for radiotherapy planning. Physics in Medicine and Biology 51, 4147 (2006). DOI: 10.1088/0031-9155/51/17/003
58. Plathow, C., Fink, C., Ley, S., Puderbach, M., Eichinger, M., Zuna, I., Schmähl, A., Kauczor, H. U. Measurement of tumor diameter-dependent mobility of lung tumors by dynamic MRI. Radiotherapy and Oncology 73, 349-354 (2004). DOI: 10.1016/j.radonc.2004.07.017
59. Cai, J., Read, P. W., Larner, J. M., Jones, D. R., Benedict, S. H., Sheng, K. Reproducibility of interfraction lung motion probability distribution function using dynamic MRI: statistical analysis. International Journal of Radiation Oncology* Biology* Physics 72, 1228-1235 (2008). DOI: 10.1016/j.ijrobp.2008.07.028
60. Mori, T., Nomori, H., Ikeda, K., Kawanaka, K., Shiraishi, S., Katahira, K., Yamashita, Y. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. Journal of Thoracic Oncology 3, 358 (2008). DOI: 10.1097/JTO.0b013e318168d9ed
61. Pauls, S., Breining, T., Muche, R., Schmidt, S. A., Wunderlich, A., Krüger, S., Brambs, H. J., Feuerlein, S. The role of dynamic, contrast-enhanced MRI in differentiating lung tumor subtypes. Clinical Imaging 35, 259 (2011). DOI: 10.1016/j.clinimag.2010.07.002
62. Bates, E. L., Bragg, C. M., Wild, J. M., Hatton, M. Q. F., Ireland, R. H. Functional image-based radiotherapy planning for non-small cell lung cancer: A simulation study. Radiotherapy and Oncology 93, 32-36 (2009). DOI: 10.1016/j.radonc.2009.05.018
63. Ireland, R. H., Bragg, C. M., McJury, M., Woodhouse, N., Fichele, S., van Beek, E. J. R., Wild, J. M., Hatton, M. Q. Feasibility of image registration and intensity-modulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer. International Journal of Radiation Oncology* Biology* Physics 68, 273-281 (2007). DOI: 10.1016/j.ijrobp.2006.12.068
64. Yankelevitz, D. F., Henschke, C. I., Batata, M., Kim, Y. S., Chu, F. Lung cancer: evaluation with MR imaging during and after irradiation. Journal of Thoracic Imaging 9, 41 (1994).
65. Hunter, G. J., Hamberg, L. M., Choi, N., Jain, R. K., McCloud, T., Fischman, A. J. Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism. Clinical Cancer Research 4, 949-955 (1998).
66. Ohno, Y., Nogami, M., Higashino, T., Takenaka, D., Matsumoto, S., Hatabu, H., Sugimura, K. Prognostic value of dynamic MR imaging for non small cell lung cancer patients after chemoradiotherapy. Journal of Magnetic Resonance Imaging 21, 775-783 (2005). DOI: 10.1002/jmri.20297
67. Mcjury, M., O'Neill, A., Lawson, M., Mcgrath, C., Grey, A., Page, W., O'Sullivan, J. Assessing the image quality of pelvic MR images acquired with a flat couch for radiotherapy treatment planning. British Journal of Radiology 84, 750-755 (2011). DOI: 10.1259/ bjr/27295679
68. Rosewall, T., Kong, V., Vesprini, D., Catton, C., Chung, P., Ménard, C., Bayley, A. Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses. Radiotherapy and Oncology 90, 325-330 (2009). DOI: 10.1016/j.radonc.2008.11.015
69. Khoo, V., Padhani, A., Tanner, S., Finnigan, D., Leach, M., Dearnaley, D. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study. British Journal of Radiology 72, 590-597 (1999).
70. Haider, M. A., Chung, P., Sweet, J., Toi, A., Jhaveri, K., Ménard, C., Warde, P., Trachtenberg, J., Lockwood, G., Milosevic, M. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. International Journal of Radiation Oncology* Biology* Physics 70, 425-430 (2008). DOI: 10.1016/j.ijrobp.2007.06.029
71. McLaughlin, P. W., Narayana, V., Meirowitz, A., Troyer, S., Roberson, P. L., Gonda, R., Sandler, H., Marsh, L., Lawrence, T., Kessler, M. Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI. International Journal of Radiation Oncology* Biology* Physics 61, 20-31 (2005). DOI: 10.1016/j. ijrobp.2004.04.070
72. van der Heide, U. A., Korporaal, J. G., Groenendaal, G., Franken, S., van Vulpen, M. Functional MRI for tumor delineation in prostate radiation therapy. Imaging 3, 219-231 (2011). DOI: 10.2217/ iim.11.10
73. Chopra, S., Menard, C., Bristow, R., Toi, A., Milosevic, M., Haider, M. in RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. A2_2. DOI: 10.1055/s-0028-1085911
74. Jiménez De La Peña, M., Martínez de Vega Fernández, V., Recio Rodríguez, M., Carrascoso Arranz, J., Herráiz Hidalgo, L., Alvarez Moreno, E. Current imaging modalities in the diagnosis of cervical cancer. Gynecologic Oncology 110, S49-S54 (2008). DOI: 10.1016/j.ygyno.2008.05.030
75. Mitchell, D. G., Snyder, B., Coakley, F., Reinhold, C., Thomas, G., Amendola, M., Schwartz, L. H., Woodward, P., Pannu, H., Hricak, H. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. Journal of Clinical Oncology 24, 5687-5694 (2006). DOI: 10.1200/JCO.2006.07.4799
76. Rockall, A. G., Sohaib, S. A., Harisinghani, M. G., Babar, S. A., Singh, N., Jeyarajah, A. R., Oram, D. H., Jacobs, I. J., Shepherd, J. H., Reznek, R. H. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. Journal of Clinical Oncology 23, 2813-2821 (2005). DOI: 10.1200/ JCO.2005.07.166
77. Dimopoulos, J. C. A., Schard, G., Berger, D., Lang, S., Goldner, G., Helbich, T., Pötter, R. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. International Journal of Radiation Oncology* Biology* Physics 64, 1380-1388 (2006). DOI: 10.1016/j.ijrobp.2005.10.017
78. Ozsarlak, O., Tjalma, W., Schepens, E., Corthouts, B., Beeck, B., Van Marck, E., Parizel, P., De Schepper, A. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma. Eur Radiol 13, 2338-2345 (2003). DOI: 10.1007/s00330-003-1928-2
79. Lim, K., Small, W. Jr, Portelance, L., Creutzberg, C., Jürgenliemk- Schulz, I. M., Mundt, A., Mell, L. K., Mayr, N., Viswanathan, A., Jhingran, A., Erickson, B., De Los Santos, J., Gaffney, D., Yashar, C., Beriwal, S., Wolfson, A., Taylor, A., Bosch, W., El Naqa, I., Fyles, A. Consensus Guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. International Journal of Radiation Oncology*Biology*Physics 79, 348-355 (2011). DOI: 10.1016/j. ijrobp.2009.10.075
80. Wu, D. H., Mayr, N. A., Karatas, Y., Karatas, R., Adli, M., Edwards, S. M., Wolff, J. D., Movahed, A., Montebello, J., Yuh, W. T. C. Inter-observer variation in cervical cancer tumor delineation for image-based radiotherapy planning among and within different specialties. Journal of Applied Clinical Medical Physics 6 (2005). DOI: 10.1120/ jacmp.v6i4.2117
81. van de Bunt, L., van der Heide, U. A., Ketelaars, M., de Kort, G. A. P., Jürgenliemk-Schulz, I. M. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression. International Journal of Radiation Oncology*Biology*Physics 64, 189-196 (2006). DOI: 10.1016/j.ijrobp.2005.04.025
82. van de Bunt, L., Jürgenliemk-Schulz, I. M., de Kort, G. A. P., Roesink, J. M., Tersteeg, R. J. H. A., van der Heide, U. A. Motion and deformation of the target volumes during IMRT for cervical cancer: What margins do we need? Radiotherapy and Oncology 88, 233-240 (2008). DOI: 10.1016/j.radonc.2007.12.017
83. Kerkhof, E. M., van der Put, R. W., Raaymakers, B. W., van der Heide, U. A., Jürgenliemk-Schulz, I. M., Lagendijk, J. J. W. Intrafraction motion in patients with cervical cancer: The benefit of soft tissue registration using MRI. Radiotherapy and Oncology 93, 115-121 (2009). DOI: 10.1016/j.radonc.2009.07.010
84. Levy, A., Caramella, C., Chargari, C., Medjhoul, A., Rey, A., Zareski, E., Boulet, B., Bidault, F., Dromain, C., Balleyguier, C. Accuracy of diffusion-weighted echo-planar MR imaging and ADC mapping in the evaluation of residual cervical carcinoma after radiation therapy. Gynecologic Oncology (2011). DOI: 10.1016/ j.ygyno.2011.06.009
85. Chan, P., Dinniwell, R., Haider, M. A., Cho, Y.-B., Jaffray, D., Lockwood, G., Levin, W., Manchul, L., Fyles, A., Milosevic, M. Inter- and Intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study. International Journal of Radiation Oncology* Biology* Physics 70, 1507-1515 (2008). DOI: 10.1016/j. ijrobp.2007.08.055
86. Hatano, K., Sekiya, Y., Araki, H., Sakai, M., Togawa, T., Narita, Y., Akiyama, Y., Kimura, S., Ito, H. Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. International Journal of Radiation Oncology*Biology*Physics 45, 639-644 (1999). DOI: 10.1016/s0360-3016(99)00228-x
87. McVeigh, P., Syed, A., Milosevic, M., Fyles, A., Haider, M. Diffusion-weighted MRI in cervical cancer. European Radiology 18, 1058-1064 (2008). DOI: 10.1007/s00330-007-0843-3
88. Haie-Meder, C., Pötter, R., Van Limbergen, E., Briot, E., De Brabandere, M., Dimopoulos, J., Dumas, I., Hellebust, T. P., Kirisits, C., Lang, S. Recommendations from gynaecological (GYN) GEC-ESTRO working group: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiotherapy and Oncology 74, 235-245 (2005). DOI: 10.1016/j.radonc.2004.12.015
89. Scheffler, K., Lehnhardt, S. Principles and applications of balanced SSFP techniques. European Radiology 13, 2409-2418 (2003). DOI: 10.1007/s00330-003-1957-x
90. Haase, A., Frahm, J., Matthaei, D., Hanicke, W., Merboldt, K. D. FLASH imaging. Rapid NMR imaging using low flip-angle pulses. Journal of Magnetic Resonance (1969) 67, 258-266 (1986).
91. Raaijmakers, A., Raaymakers, B., Lagendijk, J. Experimental verification of magnetic field dose effects for the MRI-accelerator. Physics in Medicine and Biology 52, 4283 (2007). DOI: 10.1088/0031-9155/52/14/017
92. Raaijmakers, A., Raaymakers, B., Lagendijk, J. Magnetic-field-induced dose effects in MR-guided radiotherapy systems: dependence on the magnetic field strength. Physics in Medicine and Biology 53, 909 (2008). DOI: 10.1088/0031-9155/53/4/006
93. Raaijmakers, A., Raaymakers, B., Van der Meer, S., Lagendijk, J. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: impact of the surface orientation on the entrance and exit dose due to the transverse magnetic field. Physics in Medicine and Biology 52, 929 (2007). DOI: 10.1088/0031-9155/52/4/005
94. Oborn, B. M., Metcalfe, P., Butson, M., Rosenfeld, A. High resolution entry and exit Monte Carlo dose calculations from a linear accelerator 6 MV beam under the influence of transverse magnetic fields. Medical Physics 36, 3549 (2009). DOI: 10.1118/1.3157203
95. Oborn, B. M., Metcalfe, P., Butson, M., Rosenfeld, A. Monte Carlo characterization of skin doses in 6 MV transverse field MRI-linac systems: effect of field size, surface orientation, magnetic field strength, and exit bolus. Medical Physics 37, 5208 (2010). DOI: 10.1118/1.3488980
96. Kirkby, C., Stanescu, T., Rathee, S., Carlone, M., Murray, B., Fallone, B. Patient dosimetry for hybrid MRI-radiotherapy systems. Medical Physics 35, 1019 (2008). DOI: 10.1118/1.2839104
97. Keyvanloo, A., Burke, B., Warkentin, B., Tadic, T., Rathee, S., Kirkby, C., Santos, D., Fallone, B. Skin dose in longitudinal and transverse linac-MRIs using Monte Carlo and realistic 3D MRI field models. Medical Physics 39, 6509 (2012). DOI: 10.1118/1.4754657
98. Beavis, A., Gibbs, P., Dealey, R., Whitton, V. Radiotherapy treatment planning of brain tumours using MRI alone. British Journal of Radiology 71, 544-548 (1998).
99. Lee, Y. K., Bollet, M., Charles-Edwards, G., Flower, M. A., Leach, M. O., McNair, H., Moore, E., Rowbottom, C., Webb, S. Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone. Radiotherapy and Oncology 66, 203-216 (2003). DOI: 10.1016/S0167-8140(02)00440-1
100. Jonsson, J. H., Karlsson, M. G., Karlsson, M., Nyholm, T. Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regions. Radiat Oncol 5, 62 (2010). DOI: 10.1186/1748-717X-5-62